Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder (2022)
- Authors:
- USP affiliated authors: CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; GUIMARÃES, FRANCISCO SILVEIRA - FMRP ; ZUARDI, ANTONIO WALDO - FMRP
- Unidade: FMRP
- DOI: 10.1007/s00213-021-06043-y
- Subjects: ANSIEDADE; FARMACOTERAPIA; CANABINOIDES; TRANSTORNOS DA ANSIEDADE; TRANSTORNO DO STRESS PÓS-TRAUMÁTICO
- Keywords: Posttraumatic stress disorder; Aversive memories; Memory reconsolidation; Cannabidiol
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Heidelberg
- Date published: 2022
- Source:
- Título: Psychopharmacology
- ISSN: 0033-3158
- Volume/Número/Paginação/Ano: v. 239, n. 5, p. 1499-1507, 2022
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
BOLSONI, Lívia Maria et al. Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder. Psychopharmacology, v. 239, n. 5, p. 1499-1507, 2022Tradução . . Disponível em: https://doi.org/10.1007/s00213-021-06043-y. Acesso em: 11 fev. 2026. -
APA
Bolsoni, L. M., Crippa, J. A. de S., Hallak, J. E. C., Guimarães, F. S., & Zuardi, A. W. (2022). Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder. Psychopharmacology, 239( 5), 1499-1507. doi:10.1007/s00213-021-06043-y -
NLM
Bolsoni LM, Crippa JA de S, Hallak JEC, Guimarães FS, Zuardi AW. Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder [Internet]. Psychopharmacology. 2022 ; 239( 5): 1499-1507.[citado 2026 fev. 11 ] Available from: https://doi.org/10.1007/s00213-021-06043-y -
Vancouver
Bolsoni LM, Crippa JA de S, Hallak JEC, Guimarães FS, Zuardi AW. Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder [Internet]. Psychopharmacology. 2022 ; 239( 5): 1499-1507.[citado 2026 fev. 11 ] Available from: https://doi.org/10.1007/s00213-021-06043-y - Is the highest density of CB1 receptors in paranoid schizophrenia a correlate of endocannabinoid system functioning?
- Effects of minocycline on regional cerebral blood flow in schizophrenia
- Canabidiol: possíveis aplicacões terapêuticas em psicopatologias
- Cannabidiol, a cannabis sativa constituent, as an antipsycholic drug
- Possible therapeutic uses of cannabidiol in anxiety disorders and schizophrenia
- A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation
- Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial]
- Cannabidiol and neuroprotection: evidence from preclinical studies
- Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13
- Marijuana, feijoada and the debate on drug legalization
Informações sobre o DOI: 10.1007/s00213-021-06043-y (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003113997.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
